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Abstract 
 
Several recent studies have estimated the responsiveness of mortality to English NHS 
spending.  Although broadly similar, the studies differ in how they identify the outcome 
equation.  One approach uses conventional socio-economic variables as instruments for 
endogenous health care expenditure while the other exploits exogenous elements in the 
resource allocation formula for local budgets.  The former approach has usually been applied 
to specific disease areas (for example, for cancer and circulatory disease) while the other has 
only been applied to all-cause mortality.  In this letter we compare the two approaches by 
using them to estimate the direct all-cause elasticity as well as disease-specific elasticities.  
We also calculate the implied all-cause elasticity associated with the disease-specific results.  
We find that WKHµIXQGLQJUXOH¶DSSURDFKWRLGHQWLILFDWLRQFDQEHVXFFHVVIXOO\UHSOLFDWHGDQG
applied to disease area models.   This is important because disease area models reduce the 
danger of aggregation bias present in all-cause analysis, and they offer the opportunity to link 
estimated mortality effects to more complete measures of health outcome that reflect what is 
currently known about the survival and morbidity disease burden in different programmes.   
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1. Introduction 
Work by Claxton et al (2015, 2017) uses English data on disease-specific expenditure and 
mortality to estimate the health opportunity cost of NHS spending.  Using a conventional 
instrumental variable approach, this work estimates (own programme) outcome and 
expenditure elasticities for each disease area.  The study combines these elasticities with 
information about the burden of disease to obtain a cost per QALY of just under £13,000 for 
NHS expenditure in 2008 (Claxton et al, 2015 and 2017).  The disease-specific elasticities are 
also used to calculate an implied all-cause elasticity of mortality with respect to health 
expenditure, and the value of this elasticity is -0.795 for 2008 (Claxton et al, 2017).    
 
Andrews et al (2017) use a very similar dataset but a rather different estimation approach.   
Rather than estimate disease-specific elasticities, Andrews et al (2017) directly estimate the 
all-cause elasticity of mortality with respect to total health expenditure.  The estimation of 
this (all programme) outcome elasticity is complicated by the fact that expenditure (both in 
total and for individual programmes) is likely to be endogenous and, therefore, should be 
instrumented.  Claxton et al (2015, 2017) use various socio-economic variables as 
instruments and their approach has met with some criticism (for example, Barnsley et al 
(2013) question the reliability of expenditure data for individual programme budget 
categories).1  Andrews et al note that the per capita budget assigned to each health authority is 
the product the national per capita budget and four adjustments reflecting local circumstances 
(eg the age index reflects the demographic profile of the local population).  Andrews et al 
argue that three of these four adjustment factors are uncorrelated with mortality and, 
                                                          
1
 Barnsley et al (2013) also criticise how the elasticities estimated by Claxton et al (2015) 
were linked to more complete measures of health outcomes (QALYs), and whether the 
assumptions necessary for such calculations were optimistic or pessimistic with respect to 
health outcomes. 
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therefore, can be used as instruments for total expenditure.  Using these so-calOHGµIXQGLQJ
UXOH¶LQVWUXPHQWV$QGUHZVHWDOUHSRUWDQDOO-cause elasticity of mortality with respect to 
NHS expenditure of -0.705 for 2005.   
 
This letter reports the findings from an exploratory study that uses the Andrews et al funding 
rule instruments to estimate disease-specific outcome elasticities.  This approach builds on 
the strengths of the studies mentioned above.  First, the use of disease-specific expenditure 
and mortality data facilitates the use of burden of disease information to convert the cost per 
life year results into more useful cost per QALY estimates.  Second, the use of the Andrews 
et al funding rule instruments permits an examination of what impact this alternative 
approach to identification has on the estimated outcome elasticity and implied cost per 
QALY of NHS expenditure.   
 
2. Methods 
The English National Health Service (NHS) is a centrally planned and publicly funded health 
care system.  Its revenue derives almost entirely from national taxation, and access to the 
system is generally free to the patient.  Primary care is an important element of the system, 
and general practitioners act as gatekeepers to secondary care and pharmaceuticals.  The 
system is organized geographically, with responsibility for the local administration of the 
NHS devolved to local health authorities.  Until April 2013 these authorities were known as 
Primary Care Trusts (PCTs).  PCTs were allocated fixed annual budgets by the national 
ministry, within which they were expected to meet expenditure on most aspects of health 
care, including inpatient, outpatient and community care, primary care and pharmaceutical 
prescriptions (Claxton et al, 2015). 
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The share of the national budget allocated to each PCT was determined by the Department of 
+HDOWK¶VIunding rule.  This rule reflected HDFK3&7¶VH[SHQGLWXUHQHHGV and this, in turn, 
reflected their population size, age profile, local input prices, and other need factors.  
Periodically, the Department revised its funding rule and this generated a new target 
allocation for each PCT.   For some PCTs, the new funding rule might result in a large 
change in its target allocation and, to avoid sudden large reductions in actual allocations 
(budgets), such changes were usually phased in over a number of years.   
 
Andrews et al (2017, p31) QRWHWKDWHDFK3&7¶Vannual allocation of health expenditure could 
be expressed as: 
 
Health Expenditure per person= (National Budget per person) * (Age Index) * 
 
   (Additional Needs Index) * (Input Price Index) * (DFT Index) (1) 
 
where: (a) the age index reflects the demographic profile of the local population; (b) the 
additional needs index reflects local deprivation and other factors likely to influence the need 
for health care; (c) the input price index reflects prices in the local health economy; and (d) 
the distance from target (DFT) index reflects how far each 3&7¶VDFtual allocation is from its 
target allocation.  The four index adjustments all take a mean value of one (Andrews et al, 
2017, p31). 
 
The health outcome equation estimated by both Claxton et al (2015, 2017) and Andrews et al 
(2017) is of the form: 
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 ln (mortality rate) = ln (health expenditure per person) + controls + e  (2) 
 
where expenditure is likely to be endogenous, the controls reflect the need for health care 
expenditure, and e reflects everything not included elsewhere in the specification.  As 
controls, Claxton et al use a small number census based indicators of deprivation (eg the 
proportion of lone parent households) while Andrews et al use measures of education 
deprivation and income deprivation in older people.  The use of different controls by the two 
research teams is considered to be of relatively little importance. 
 
However, there is considerably more debate about the appropriate approach to identification.  
In their disease-specific work, Claxton et al use various socio-economic variables (such as the 
proportion of the population providing unpaid care) as instruments for expenditure.  For their 
all-cause specification, Andrews et al argue that there is no need to use these variables as 
instruments because three of the four adjustment factors in (1) are unlikely to be correlated 
with mortality and therefore are appropriate instruments for total expenditure.  The only 
exception is the additional needs index which is potentially endogenous because it contains 
historical mortality (reverse causation). Using three of these so-FDOOHGµIXQGLQJUXOH¶variables 
as instruments, Andrews et al report an all-cause elasticity of mortality with respect to NHS 
expenditure of -0.705 for 2005.   
 
With only an all-cause elasticity and no disease-specific detail, it is very difficult to convert 
the Andrews et al elasticity to a cost per QALY basis.  To overcome this problem, we re-
estimate equation (2) for the four largest (in terms of mortality) disease categories: for cancer, 
circulatory disease, respiratory disease, and gastro-intestinal problems.   As our starting point 
we use the funding rule variables identified by Andrews et al as instruments.  Theory 
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provides little guidance as to the appropriate controls so, following Claxton et al, we identify 
a dozen socio-economic variables such as the proportion of lone pensioner households, the 
proportion of the population providing unpaid care, and the proportion of owner-occupied 
households (Claxton et al, 2015).   
 
For each disease area, we start by estimating (2) with all socio-economic variables included 
as controls.  The least significant regressor is removed from the specification and the 
equation is re-estimated.  This process ± of dropping the least significant regressor and re-
estimating -- continues until there are only significant controls remaining.  This specification 
becomes our preferred result if it also passes the appropriate statistical tests (eg the 
instruments are valid, and the instruments are strong) but, if this is not the case, the 
specification is adjusted (eg an invalid instrument is removed) and the equation re-estimated.   
 
3.  Data 
Andrews et al use mortality and programme budgeting expenditure data for 152 PCTs for 
2005/06 and, for comparability purposes, we adopt the same study year in this exploratory 
analysis.   Expenditure and DFT data by PCT and disease area are available from the 
'HSDUWPHQWRI+HDOWK¶VZHEVLWH>VHHKWWSVZZZHQJODQGQKVXNUHVRXUFHVUHVRXUFHV-for-
ccgs/prog-budgeting/] and historical mortality data is available on request from NHS Digital.  
The latest release of mortality data (for 2012-14) is available via the NHS Digital Indicator 
portal [see https://indicators.hscic.gov.uk/webview/].   We use the age/gender standardised 
rate of years of life lost (SYLLR) as the measure of mortality (Claxton, 2015).  
 
7KH'HSDUWPHQWRI+HDOWK¶VUHVRXUFHDOORFDWLRQERRNVfor 2003/4, 2004/5 and 2005/6 can be 
used to extract the relevant age and MFF indices for Hospital and Community Health 
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Services (HCHS) [see 
http://webarchive.nationalarchives.gov.uk/20090120134027/http://dh.gov.uk/en/Managingyo
urorganisation/Financeandplanning/Allocations/DH_4000344].  These allocations were for 
the 303 PCTs in existence in April 2003.  In October 2006 there was a major re-organisation 
of PCTs and their number was reduced from 303 to 152.  The mortality data for 2005-07 was 
constructed after this re-organisation and therefore relates to 152 PCTs.  As we do not have 
an appropriate mapper to convert the age and MFF indices for the 303 PCTs to 152, we 
consulted later (post-reorganisation) resource allocation books for proxies for these variables.  
The resource allocation book for 2009/10 contains a MFF for HCHS but the age index for 
HCHS is combined with the additional need index for this year.  As we want a pure age 
index, we use the age index for prescribing services from the allocation book for this year 
[see 
http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Managingyourorganisation/F
inanceandplanning/Allocations/DH_091850].   The socio-economic variables are constructed 
using 2001 population census data. 
 
4. Results 
Table 1 shows our preferred specifications for the all-cause and the four disease-specific 
models.  In all five cases the test statistics show that expenditure is endogenous, that the 
instruments are valid, and that they can be considered to be strong instruments (F statistic 
value about ten or better).    
 
Column (1) reveals that the outcome elasticity for the all-cause model is -1.089.  As all 
variables are measured as logarithms, this implies that 1% increase in expenditure per person 
is associated with a 1.089% reduction in mortaOLW\7KLVVSHFLILFDWLRQH[FOXGHVWKHµGLVWDQFH
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IURPWDUJHW¶YDULDEOHDVan instrument because the Hansen-Sargan test statistic suggests that 
this is not a valid instrument. 
 
The outcome elasticity for expenditure on cancer is -0.272 (see column (2)).  This result 
includes all three funding rule variables as instruments.  Column (3) reveals a significant 
outcome elasticity (=-2.450) for expenditure on circulatory disease and again this result 
includes all three funding rule variables as instruments. 
 
Column (4) shows that the outcome elasticity for expenditure on respiratory disease is -2.194 
and that this figure is statistically significant at the 5% level.  This result only incorporates a 
single instrument (the input price index) although a very similar result is obtainable (with a 
coefficient of -2.355) if the MFF index is added to the specification.  However, the addition 
of this extra instrument generates a slightly weaker set of instruments (Kleibergen-Paap F 
statistic=7.070) so we favour the single instrument specification (Angrist and Pischke, 2009). 
 
Finally, the outcome elasticity for expenditure on gastro-intestinal problems is -2.888 (see 
column (5)) and this estimate is statistically significant at the 1% level.   This result also 
omits one of the funding rule variables (the distance from target index) as the Hansen-Sargan 
test suggests that this is not a valid instrument. 
 
5. Discussion 
The results presented above can be compared with previous estimates.  First, the all-cause 
outcome elasticity (=-1.089) is slightly larger (absolutely) than that (=-0.705) reported by 
Andrews et al (2017) for the same year (2005) but both values are within the 95% confidence 
interval of each other.  There are various reasons why the two estimates might differ: first, 
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Andrews et al use different controls (education deprivation and income deprivation in older 
people) to those employed here; second, Andrews et al use a directly age-standardised 
mortality rate as their outcome variable but we use a directly age-standardised years of life 
lost rate; third, Andrews et al use the HCHS age index (for 2005/6 allocations) as an 
instrument but we use the prescribing age index (for 2009/10 allocations); and fourth, we 
weight observations by PCT population size when estimating the regressions (because PCTs 
differ greatly in size) but Andrews et al appear to give the same weight to each PCT.  
 
The all-cause elasticity reported in Table 1 (=-1.089) can also be compared with the implied 
all-cause elasticity obtained from disease-specific work.  Claxton et al (2017) use data on 
mortality and expenditure to estimate disease-specific outcome elasticities for 2005.  These 
elasticities can be used to calculate an implied all-cause elasticity (=-1.372) and its associated 
95% confidence interval (-1.905, -0.890).  The directly estimated all-cause elasticity might be 
smaller (absolutely) than the implied all-cause value from the disease-specific results due to 
the presence of aggregation bias in the directly estimated all-cause specification. 
 
The disease-specific (all programme) outcome elasticities reported in Table 1 and 
summarised in column 1 of Table 2 can be compared with disease-specific (own programme) 
outcome elasticities obtained with the use of a different set of (non-funding rule) instruments.  
Claxton et al (2017) use various socio-economic indicators as instruments and the outcome 
elasticities associated with a change in own programme expenditure are shown in the  second 
column of Table 2.  These elasticities are associated with a small change in own programme 
expenditure so they cannot be directly compared with the elasticities shown in  column 1 
because the latter reflect a small change in the total (not own programme) budget.  
Fortunately, however, Claxton et al (2017) also report expenditure elasticities; these show the 
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change in own programme expenditure that is associated with a change in total budget (see 
column 3 of Table 2).  If we form the product of the elasticities shown in columns 2 and 3 of 
Table 2, we obtain the elasticities shown in column 4 and, as these reflect the responsiveness 
of mortality to a small change in total budget, they can be directly compared with the 
outcome elasticities shown in Table 1 and reproduced in column 1 of Table 2.  This 
comparison reveals that the choice of instruments has virtually no impact on the elasticities 
for both cancer and circulatory disease.  The funding rule outcome elasticity for respiratory 
disease is slightly smaller than that obtained with the use of socio-economic instruments, and 
the funding rule outcome elasticity for gastro-intestinal problems is larger than that obtained 
with the use of socio-economic instruments.  
 
One advantage of the funding rule approach over that of Claxton (2015, 2017) is that, by 
using total expenditure rather than individual programme expenditure, it is less susceptible to 
questions about the reliability of individual programme budget data.  Moreover, the study of 
the impact of own programme expenditure on PBC outcome means that the resulting 
elasticity is unable to reflect the impact of other programme expenditure on own programme 
mortality.  Similarly, own programme expenditure might be contributing to other programme 
mortality.  If co-morbidities are important, we would expect the (all budget) outcome 
elasticities to be larger (absolutely) than the own programme outcome elasticities because the 
former will reflect the impact of spending in all programmes on programme-specific 
mortality, whereas the own programme outcome elasticities will only reflect spending in the 
specific programme. 
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6.  Conclusion 
Although these results are only for one year and only for four programmes, they provide no 
evidence to suggest that an entirely different approach to identification generates materially 
different results.  These findings also suggest that the µIXQGLQJUXOH¶approach to 
identification can be successfully replicated and applied to disease area models.   This is 
important because disease area models reduce the danger of aggregation bias present in all-
cause analysis, and they offer the opportunity to link estimated mortality effects to more 
complete measures of health outcome that reflect what is currently known about the survival 
and morbidity disease burden in different programmes.   
 
7KHµIXQGLQJUXOH¶ approach to instrumentation combined with its application at disease area 
level is likely to provide a secure foundation for re-estimating health opportunity costs as data 
on expenditure and outcomes by programme evolve in the UK.  This approach also points to 
fruitful ways to investigate health opportunity costs in other health care systems where there 
are exogenous elements in resource allocation mechanisms. 
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Table 1  Preferred outcome specifications for all-cause mortality and four disease-specific causes of mortality 
 
  (1) (2) (3) (4) (5) 
 
PBC All PBC 02 PBC 10 PBC 11 PBC 13 
 
2005/06 spend 2005/06 spend 2005/06 spend 2005/06 spend 2005/06 spend 
 
SYLLR 2005/06/07 SYLLR 2005/06/07 SYLLR 2005/06/07 SYLLR 2005/06/07 SYLLR 2005/06/07 
VARIABLES all cause outcome cancer outcome circulatory outcome respiratory outcome gastro outcome 
            
Expenditure per person -1.089*** -0.272 -2.450*** -2.194** -2.888*** 
 
[0.359] [0.175] [0.539] [1.013] [0.995] 
Controls 
     Proportion of residents born outside the EU 
 
-0.052*** 
   
  
[0.009] 
   Proportion of population aged 16-74 without qualifications 
 
0.094** 
   
  
[0.039] 
   Proportion of one parent households 0.296*** 0.337*** 
 
0.446*** 
 
 
[0.048] [0.047] 
 
[0.154] 
 Proportion of owner occupier households -0.541*** -0.225** -0.419** -0.956** 
 
 
[0.162] [0.102] [0.186] [0.420] 
 Proportion of households without a car 
  
1.029*** 
 
2.400*** 
   
[0.142] 
 
[0.851] 
Proportion of those aged 16-74 in professional occupations 
  
-0.331*** 
  
   
[0.089] 
  Proportion of those aged 16-74 in employment in agriculture 
   
-0.119*** 
 
    
[0.038] 
 Proportion of population aged 16-74 with a limiting long-term illness 0.651*** 
  
1.195*** 4.452** 
 
[0.104] 
  
[0.319] [2.137] 
      Constant 8.437*** 5.903*** 6.011*** 6.546*** 12.335*** 
 
[0.271] [0.119] [0.342] [0.539] [2.428] 
      Observations (PCTs) 152 152 152 152 152 
Endogeneity test statistic 19.361 3.452 28.750 7.541 9.677 
Endogeneity p-value 0.000 0.063 0.000 0.006 0.002 
Hansen-Sargan test statistic 0.842 3.586 0.396 
 
0.063 
Hansen-Sargan p-value 0.359 0.166 0.820 
 
0.801 
Kleibergen-Paap LM test statistic 14.302 20.794 21.890 8.896 15.111 
Kleibergen-Paap p-value 0.001 0.000 0.000 0.003 0.001 
Kleibergen-Paap F statistic 9.411 12.305 11.641 9.618 10.066 
Pesaran-Taylor reset statistic 0.004 1.375 0.007 0.043 0.396 
Pesaran-Taylor p-value 0.951 0.241 0.931 0.835 0.529 
Notes: (i) Robust standard errors in brackets; ***p<0.01, **p<0.05, *p<0.01. 
     (ii) The gastro-intestinal specification also includes two squared controls (households with no car and population with a limiting long-term illness). 
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Table 2  Comparing outcome elasticities using different approaches to identification 
 
  Using funding rule variables as instruments Using socio-economic variables as instruments 
 
Outcome elasticity Outcome elasticity Expenditure elasticity Implied outcome elasticity 
 
associated with a 1% associated with a 1% associated with a 1% associated with a 1% 
 
increase in total budget increase in own increase in total budget  increase in total budget 
 
  programme expenditure 
  
Disease area (1) (2) (3) (4) 
Cancer -0.272 -0.159 1.592 -0.253 
Circulatory disease -2.450 -1.637 1.477 -2.418 
Respiratory disease -2.194 -2.217 1.225 -2.716 
Gastro-intestinal problems -2.888 -1.014 1.076 -1.091 
 
 
 
 
 
 
 
 
